There is a Fortune to be Made in the Legal Cannabis Market!

Savvy Investors are Positioning in Early

Even the mainstream media is starting to catch on, believe it or not. Of course, though, they’re a lagging indicator as usual. The headline out of Newsweek speaks volumes:

Courtesy of Newsweek online

Yes, marijuana legalization is on a roll; I certainly won’t argue with that. And there’s no question that Canada is launching a legal marijuana market: they’ve been doing this for years! Canada is a progressive and forward-thinking nation when it comes to cannabis, and full legalization (including adult recreational use) has been supported by the majority of Canadian citizens for quite a while now:

Courtesy of CTV News/Nanos Research

What I have uncovered is a way to position in this trend early before the massive wave of Johnny-come-lately investors comes around. We want to be in front of this massive trend.

We here at Crush The Street have been following this industry and seeking out a company that will richly reward investors who are prepared to make a fortune in legalized cannabis, and I am informing you today that we’ve identified this company as C21 Investments Inc. (CSE:CXXI).

But before we get into more of the details on C21 Investments, it’s important that you understand how big of a deal this trend is going to be and the type of names that are advancing it further.

Canadian Prime Minister Justin Trudeau has shown his full support for cannabis legalization, thereby giving the green light and eliminating all roadblocks:

Courtesy of Twitter, Newsweek online

In the United States, cannabis products are fully legal for both medicinal and adult recreational uses in nine states, as well as Washington, D.C. Cannabis for medical use is legally permitted in a total of 31 states, plus there are 12 states that allow cannabis use for specific medical conditions. In addition to all of this, there are several U.S. states that have ballot measures coming up later this year. If Mexico legalizes it for all uses – and the incoming government has suggested that it may do this – the entire length of North America’s Pacific Coast will be unified as 100% legalized soon. Honestly, there’s no hope for anyone who wants to suppress cannabis legalization in North America.

As for my readers and I, we will be positioned in cannabis and ready for this cycle to fully set into place.

Based in Vancouver, C21 is a vertically-integrated cannabis corporation that cultivates, processes, manufactures, and distributes quality cannabis and hemp-derived consumer products with branding recognition in the United States and internationally. All of my team’s research and due diligence have led me to the conclusion that C21 will provide enormous returns in 2018.

And 2018, which will be amazing for C21, will be just the beginning. As an investor, how does an 86% increase in projected revenues in 2018 and 2019 sound? To me, it sounds like enormous profit potential:

Courtesy of C21 Investments Inc. Investor Presentation

Profitable, vertically-integrated operations with expert leadership in a growth-oriented industry that’s spreading quickly across North America and throughout the world… This could very well be my biggest winner of 2018 and 2019. Take a serious look at CXXI stock and consider a position – your cannabis fortune is ready for the taking.

All indicators point to this stock as the best way to profit from the rising trend in legal cannabis.

CEO and Director Rob Cheney has built a top-tier firm from the ground up, and C21 Investments Inc. has research-backed statistics to impress even the most discerning investor:

Courtesy of C21 Investments Inc. Investor Presentation

Just look at how C21 compares favorably to stock market giants, even beyond the marijuana market – they even outperform Apple by a wide margin. In terms of average annual revenue per square foot, nobody comes close to C21 Investments Inc.

The roadmap for the company is aggressive, and we have high regards for CEO and Director Rob Cheney in his ambitious plan that I expect will play out very favorably for investors.

The trends in the stock market are constantly changing, and it takes a great deal of hard work and decades of market experience to know what’s coming next. I’ve seen these trends come and go multiple times over the years; sectors will rotate and latecomers will get hammered every time. I know one thing for sure, though: the legal cannabis industry is flourishing as I write this, and it’s not just a short-term trend. It’s the real deal, and it’s here to stay.

C21 is a monster when it comes to value. At $1.15 per share, the company is a steal, in my opinion.

I’d like to emphasize the image above, that on the retail and distribution front, CXXI is aimed at going from 5 dispensaries to 50 between now and 2019. It currently has 544 branded products in 544 dispensaries, along with 105,000 customers per month.

This is no run of the mill start-up, but at $1.15, it sure can be purchased as one, capturing serious known value.

Cannabis Fortunes to be MADE!

The facts make it perfectly evident that any stigma attached to the marijuana plant is a thing of the past, a relic of bygone days when fear and misunderstanding dominated the headlines and politicians distorted the facts for their own benefit. Scientific breakthroughs and medical advances, combined with agricultural technologies that were unimaginable only a few years ago, have changed attitudes and governmental policies at a breakneck pace.

Without a doubt, great wealth can come to investors who place their bets early in this fascinating and highly-lucrative North American market.

I’m taking my position in CXXI stock, and you should consider taking a position today if you’re prepared to make big money in the legal cannabis market. You won’t regret going with the trend that is changing the world and making multimillionaires in 2018.

The time to be looking into C21 Investments Inc. (CSE: CXXI) is now!

Error: Contact form not found.

Best Regards,


Daniel Ameduri

Legal Notice

This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

Never base any decision off of our emails. stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish.  Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. We have been compensated by C21 Investments Inc. a digital marketing fee of three hundred thousand dollars USD. We have also received a signing fee of five hundred thousand dollars CAD. We have also been issued one million eight hundred thousand RSUs. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at